Uploaded January 2026 | Updated September 2026, 2 weeks ago
00:00 Opening Remarks
08:42 Keynote: The Value of Delaying Alzheimer’s Disease
24:28 CTRL Patient Perspectives
27:46 Panel: Closing the “Clinical Trial Translational Gap”— Approaches to Prescreening, Participant Identification and Clinical Trial Enrollment
1:14:17 Pitch Competition: Technology-Driven Approaches to Prescreening, Participant Identification and Clinical Trial Enrollment
1:57:05 Closing Remarks
Overcoming barriers to Alzheimer’s clinical trial recruitment will require varied, evidence-based approaches. The USC Clinical Trial Recruitment Lab (CTRL), a collaboration between the Schaeffer Center and the Alzheimer’s Therapeutic Research Institute, is hosting a symposium to examine how new technologies and improved diagnostics can strengthen clinical trial recruitment, shed light on the patient experience in trials, and examine the urgent economic realities for patients and families affected by the disease. The event, hosted alongside the 2025 Clinical Trials on Alzheimer’s Disease Conference, brings together leading experts from across the clinical trial ecosystem to discuss progress, identify challenges and share best practices for advancing recruitment in inclusive Alzheimer’s clinical trials.
00:00 Opening Remarks
08:42 Keynote: The Value of Delaying Alzheimer’s Disease
24:28 CTRL Patient Perspectives
27:46 Panel: Closing the “Clinical Trial Translational Gap”— Approaches to Prescreening, Participant Identification and Clinical Trial Enrollment
1:14:17 Pitch Competition: Technology-Driven Approaches to Prescreening, Participant Identification and Clinical Trial Enrollment
1:57:05 Closing Remarks
Overcoming barriers to Alzheimer’s clinical trial recruitment will require varied, evidence-based approaches. The USC Clinical Trial Recruitment Lab (CTRL), a collaboration between the Schaeffer Center and the Alzheimer’s Therapeutic Research Institute, is hosting a symposium to examine how new technologies and improved diagnostics can strengthen clinical trial recruitment, shed light on the patient experience in trials, and examine the urgent economic realities for patients and families affected by the disease. The event, hosted alongside the 2025 Clinical Trials on Alzheimer’s Disease Conference, brings together leading experts from across the clinical trial ecosystem to discuss progress, identify challenges and share best practices for advancing recruitment in inclusive Alzheimer’s clinical trials.
